FV2GP
Flagship Ventures 2007 General Partner Portfolio holdings
AUM
$107M
This Quarter Return
-2.95%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$157M
AUM Growth
–
Cap. Flow
+$157M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Agios Pharmaceuticals
AGIO
|
$92.5M |
| 2 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$46.7M |
| 3 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$15.8M |
| 4 |
BGMD
BG MEDICINE INC COM STK NEW
BGMD
|
$1.84M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 58.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Agios Pharmaceuticals
AGIO
$2.19B
| $92.5M | 58.97% |
+3,860,738
| New | +$92.5M |
|
|
RCPT
2
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $46.7M | 29.8% |
+1,611,911
| New | +$46.7M |
|
|
TTPH
3
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $15.8M | 10.05% |
+1,165,786
| New | +$15.8M |
|
|
BGMD
4
DELISTED
BG MEDICINE INC COM STK NEW
BGMD
| $1.84M | 1.17% |
+1,764,286
| New | +$1.84M |
|